department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Imatinib Mesylate · pharmadog

pharmadog
drugs
Imatinib Mesylate

drug

patient view →

Imatinib Mesylate CSPC

Marketedupdated 2mo ago

by CSPC Pharmaceutical Group Ltd

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Imatinib Mesylate

generic

imatinib mesylate

indication

Hypereosinophilic Syndrome

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 50m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 5

tagApproval106 co-mentions · 53 sources
drugimatinib mesylate99 co-mentions · 53 sources
drugGLEEVEC99 co-mentions · 53 sources
tagSmall Molecule53 co-mentions · 53 sources
drugImatinib Mesylate Shilpa53 co-mentions · 53 sources

Trials studying Imatinib Mesylate CSPC

phase4Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigatorcompletedn=250
phase1A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)recruitingn=157
phase2Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Hostcompletedn=65
phase1A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mgcompletedn=64
phase2Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanomaunknownn=22